Important notice

Meds75+ – information regarding the use for persons aged 75+

Substances A-Z
  • Ba

  • Baclofenum
    Class D
    Avoid use in older persons. Reduce the dose in even mild renal insufficiency. Significant adverse effects include tiredness, confusion, depression, nightmares, muscular weakness, hypotension and risk for falls. May potentiate the sedative effects of other simultaneously used drugs affecting the CNS.
  • Be

  • Beclometasoni dipropionas
    Class A
    Suitable for older persons.
    Class A
    Suitable for older persons. Take into account possible systemic adverse effects. Take interactions into account.
  • Betahistini dihydrochloridum
    Class A
    Suitable for older persons.
  • Betamethasoni valeras
    Class C
    Topical treatment: Suitable for older persons, with specific cautions. Note adverse local effects and systemic absorption.
  • Betaxololi hydrochloridum
    Class C
    Suitable for older persons, with specific cautions. Start and continue therapy under supervision by an ophthalmologist. Remember systemic adverse effects. Take interactions into account.
  • Bi

  • Bimatoprostum
    Class A
    Suitable for older persons. Start and continue therapy under supervision by an ophthalmologist. May cause alterations in iris pigmentation and growth of eyelashes.
  • Bisacodylum
    Class D
    Avoid use in older persons. A laxative that stimulates the intestine. Can be used temporary. Risk of paralytic ileus in prolonged use.
  • Bisoprololi fumaras
    Class A
    Suitable for older persons. Reduce the dose in severe renal insufficiency. Significant adverse effects include bradycardia and orthostatic hypotension. Take interactions into account, especially with drugs affecting the conduction pathways of the heart.
  • Bisoprololi hemifumaras
    Class A
    Suitable for older persons. Reduce the dose in severe renal insufficiency. Significant adverse effects include bradycardia and orthostatic hypotension. Take interactions into account, especially with drugs affecting the conduction pathways of the heart.
  • Br

  • Brimonidini tartras
    Class C
    Suitable for older persons, with specific cautions. Start and continue therapy under supervision by an ophthalmologist.
  • Brinzolamidum
    Class C
    Suitable for older persons, with specific cautions. Start and continue therapy under supervision by an ophthalmologist. Avoid use in severe renal insufficiency.
    Class C
    Suitable for older persons, with specific cautions. Start and continue therapy under supervision by an ophthalmologist. Avoid use in case of renal insufficiency.
    Class C
    Suitable for older persons, with specific cautions. Start and continue therapy under supervision by an ophthalmologist. Avoid use in severe renal insufficiency.
  • Bu

  • Budesonidum
    Class C
    Suitable for older persons, with specific cautions. Adverse effects to glucocorticoids are emphasised in long-term use. Take interactions into account.
    Class A
    Suitable for older persons. Take into account possible systemic adverse effects. Take interactions into account.
  • Buprenorphini hydrochloridum
    Used as "ANALGESICS"
    Class C
    Suitable for older persons, with specific cautions. Opioid. Transdermal efficacy is weak in patients with cachexy. Dosage adjustment is usually not necessary in older persons. Start a laxative to prevent constipation.
  • Buprenorphinum
    Used as "ANALGESICS"
    Class C
    Suitable for older persons, with specific cautions. Opioid. Transdermal efficacy is weak in patients with cachexy. Dosage adjustment is usually not necessary in older persons. Start a laxative to prevent constipation.
  • Bupropioni hydrochloridum
    Class C
    Suitable for older persons, with specific cautions. Take into account the risk of convulsions and numerous interactions. Reduce the dose in even mild renal insufficiency. Increases risk for falls.
  • Buspironi hydrochloridum
    Used as "PSYCHOLEPTICS"
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose in even mild renal insufficiency. Avoid consuming grapefruit during treatment.

Icon explanation

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Mar 30, 2021.